<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0008">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Alharbi</surname>
    <given-names>AF</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kratzke</surname>
    <given-names>RA</given-names>
   </name>, 
   <name name-style="western">
    <surname>D’Cunha</surname>
    <given-names>J</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Gemcitabine and metabolite pharmacokinetics in advanced NSCLC patients after bronchial artery infusion and intravenous infusion</article-title>. 
  <source>Cancer Chemother Pharmacol</source>. 
  <year>2019</year>;
  <volume>83</volume>:
  <fpage>387</fpage>–
  <lpage>391</lpage>. doi: 
  <pub-id pub-id-type="doi">10.1007/s00280-018-3757-7</pub-id>
  <pub-id pub-id-type="pmid">30542769</pub-id>
 </mixed-citation>
</ref>
